Super-selective embolisation of bladder arteries for treatment of patients with bladder tumors complicated by recurrent macrohematuria


DOI: https://dx.doi.org/10.18565/urology.2020.5.133-138

V.K. Karpov, S.A. Kapranov, B.M. Shaparov, A.A. Kamalov

1Lomonosov Moscow State University, Faculty of Fundamental Medicine, Urology and Andrology Department (Director – academician, MD Kamalov A.A.), Moscow, Russia; 2Moscow Research and Education Center of the Lomonosov Moscow State University (Director – academician, MD Kamalov A.A.), Moscow, Russia; 3Pirogov Russian National Research Medical University (Director – academician, MD Lukyanov S.A.), Moscow, Russia; 4GBUZ «GKB №31 DZM» (Director – MD Ephremova N.M.), Moscow, Russia
The prevalence of bladder cancer in Russia over the past 10 years has increased from 49.6 to 74.1 patients per 100,000 population. Hematuria is a life-threatening complication and one of the common causes of mortality in advanced stages of bladder cancer. Conservative methods of hemostasis do not always allow to achieve a stable effect. In addition, in the cases of intractable bleeding, the patients may require surgical treatment. Due to the prevalence of patients with a high anesthetic risk group in bladder cancer patients cohort, the minimally invasive hemostasis technologies are more preferable. This review is devoted to one of such methods - superselective embolization of the urinary bladder arteries.

About the Autors


Corresponding author: V.K. Karpov – MD, Lomonosov Moscow State University, Faculty of Fundamental Medicine, Urology and Andrology Department, Moscow, Russia; e-mail: vk_karpov@mail.ru


Similar Articles


Бионика Медиа